sr141716 has been researched along with neuropeptide y in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnone, M; Chaperon, F; Le Fur, G; Maruani, J; Poncelet, M; Soubrié, P; Thiébot, MH | 1 |
| Calassi, R; Maruani, J; Poncelet, M; Soubrié, P | 1 |
| Caberlotto, L; Eriksson, S; Hansson, A; Heilig, M; Rimondini, R | 1 |
| Gallate, JE; McGregor, IS | 1 |
| de Miguel, R; Fernández-Ruiz, J; Maestro, B; Michael Walker, J; Ramos, JA; Rubio, M | 1 |
| Baldock, PA; Enriquez, RF; Herzog, H; Lee, NJ; Lin, S; Nguyen, AD; Riepler, SJ; Sainsbury, A; Shi, YC; Stehrer, B; Yulyaningsih, E; Zhang, L | 1 |
6 other study(ies) available for sr141716 and neuropeptide y
| Article | Year |
|---|---|
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
Topics: Animals; Ethanol; Feeding Behavior; Injections, Intraventricular; Male; Mice; Mice, Inbred C57BL; Neuropeptide Y; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sucrose | 1997 |
Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice.
Topics: Alcohol Drinking; Animals; Eating; Food Preferences; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuropeptide Y; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sucrose | 2003 |
Corticotropin-releasing hormone (CRH) mRNA expression in rat central amygdala in cannabinoid tolerance and withdrawal: evidence for an allostatic shift?
Topics: Amygdala; Analysis of Variance; Animals; Behavior, Animal; Cannabinoids; Corticotropin-Releasing Hormone; Dose-Response Relationship, Drug; Dronabinol; Drug Administration Schedule; Drug Tolerance; Excitatory Amino Acid Antagonists; Gene Expression Regulation; In Situ Hybridization; Locomotion; Male; Maze Learning; Neostriatum; Neuropeptide Y; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Neuropeptide Y; Rimonabant; RNA, Messenger; Substance Withdrawal Syndrome; Time Factors | 2004 |
Rats on the grog: novel pharmacotherapies for alcohol craving.
Topics: Alcoholism; Animals; Baclofen; Beer; Behavior, Addictive; Cannabinoid Receptor Antagonists; Corticotropin-Releasing Hormone; Humans; Models, Animal; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Piperidines; Pyrazoles; Rats; Receptors, Corticotropin-Releasing Hormone; Receptors, GABA-B; Research Design; Rimonabant | 2004 |
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
Topics: Animals; Anxiety; Appetite; Arachidonic Acids; Autoradiography; Benzoxazines; Brain Chemistry; Cannabinoid Receptor Modulators; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Emotions; Endocannabinoids; Enkephalins; Ethanol; Ethanolamines; Glycerides; In Situ Hybridization; Male; Morpholines; Motor Activity; Naphthalenes; Neuropeptide Y; Neurotransmitter Agents; Piperidines; Polyunsaturated Alkamides; Protein Precursors; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Stress, Psychological; Substance Withdrawal Syndrome | 2008 |
Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation.
Topics: Animals; Body Composition; Eating; Energy Metabolism; Homeostasis; Mice; Neuropeptide Y; Obesity; Oxidation-Reduction; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Neuropeptide Y; Rimonabant | 2010 |